Furthermore, CD70 was induced in LSCs by upregulating transcription factor specificity protein 1 in tyrosine kinase inhibitor-treated CML patients, triggering CD27 signaling which compensated Wnt pathway and therefore ultimately causing relapse [94]. Here, CD70 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.